Skip to content
Open access

Rural-urban divide for cancer in Medicare: An analysis of utilization and outcomes in fee-for-service Medicare in 2023.

Oct 2026 · JCO Oncology Practice · Vol 22, pp. 65-65 · 0 citations

TL;DR

The rural cancer population covered by TM experienced significantly higher annual all-cause mortality and lower hospice use in 2023, and spending per beneficiary, comorbidity burdens, and common cancer prevalence were comparable between beneficiaries accessing care in urban versus rural settings in TM.

Abstract

65 Background: Individuals with cancer residing in rural areas can face unique challenges in accessing care such as transportation and clinician shortages, that may contribute to higher mortality than their urban counterparts. Rural communities often have higher rates of poverty and carcinogenic exposures (i.e., tobacco products). Recent rural hospital closures could further limit access to care. This study examines spending, hospice use, and mortality risk for beneficiaries with cancer enrolled in Traditional Fee-for-service Medicare (TM), compared by rurality. Methods: We conducted a cross-sectional study of TM cancer survivors in 2023 using Medicare Beneficiary Summary Files and Prescription Drug Event data. Beneficiaries continuously enrolled through 2023 or until date of death with 2 or more linked claims to ICD-10 cancer diagnoses codes were aggregated. Beneficiary counts were used to assess cancer prevalence and Part A/B/D specific claims were used to assess annual spending per capita and hospice utilization within 180 days of death. The Hierarchical Condition Category (HCC) counts were used to measure comorbidity burdens. Zip codes associated with claims had Rural-Urban Commuting Area Codes (RUCA) to differentiate urban and rural care settings. Measures compared by rurality were adjusted by comorbidity, cancer diagnosis and sex. Results: Our study population included 5,211,773 beneficiaries seeking care with cancer (24.9% were rural). In both rural and urban populations, the most common cancers were prostate, breast, lung and colorectal, comprising nearly half (45%) of cancer prevalence. Comorbidity burden was similar in rural and urban residents (HCC: 2.60 vs. 2.74; p=0.95). Per capita spending for Parts A and B services were similar for rural ($25,721; standard deviation or SD $44,195) and urban ($27,263; SD $48,184 ; p=0.97) residents, with most spending (86%) covered by the Medicare program and the remainder by supplemental insurance or out-of-pocket costs. Annual prescription spending was also similar for rural ($7,549; SD $1,546) and urban ($8,589; SD $1,612; p=0.5) residents with 10% of costs falling on the beneficiary as out-of-pocket costs. Hospice use among decedents was lower for rural compared to urban residents (65.0% vs 65.8%; p<0.05). Annual all-cause mortality was higher among rural than urban residents (7.5% vs. 6.7%; p<0.05) and this difference was consistent across cancer diagnoses. Conclusions: The rural cancer population covered by TM experienced significantly higher annual all-cause mortality and lower hospice use in 2023. Despite this, spending per beneficiary, comorbidity burdens, and common cancer prevalence were comparable between beneficiaries accessing care in urban versus rural settings in TM. These findings have implications for efforts to improve cancer care delivery in rural settings, especially for patients at the end-of-life.

Read PDF

Similar papers

Open access Oct 2026

County-level rural-urban variation in NSCLC treatment and survival among Medicare beneficiaries.

209 Background: Patients with non-small cell lung cancer (NSCLC) living in rural areas face numerous barriers to care. Although rural-urban disparities in lung cancer care are well documented, less is known about variation in treatment and survival across rural and urban counties or how these patterns have chan...

Tanvee Varma, Do Lee, P. Soulos et al. · 0 citations
Review Open access Sep 2026

Rural Cancer Care Delivery in the United States: A 2026 Update on Disparities, Vulnerable Populations, and Emerging Models.

Rural Americans with cancer face persistent and widening disparities in incidence, stage at diagnosis, treatment access, and mortality. This paper synthesizes evidence on the financial sustainability of rural oncology programs, the populations bearing the greatest burden of rural cancer disparities, and the care delive...

Wade Swenson, Zachary J. Schroeder · 0 citations
Open access Oct 2026

Association between insurance status, rurality, and quality of care in breast, colorectal, and lung cancer: Results from a statewide database in North Carolina.

215 Background: Despite advances in cancer treatment, disparities in cancer care quality persist. Some prior work has shown disparities by insurance type and geography, but these findings have been mixed. We analyzed whether people with three commonly diagnosed cancers (breast, colorectal, lung) received guidel...

Tess Thompson, Bradford E. Jackson, C. Baggett et al. · 0 citations
Review Open access Sep 2026

Socioeconomic disparities in access to care and healthcare expenditures among U.S. adults: evidence from the Medical Expenditure Panel Survey, 2018–2022

Background: Socioeconomic disparities in health insurance coverage, income, and education are well-established determinants of healthcare access and spending in the United States. Less is known about how these disparities manifested during 2018–2022, a period marked by major disruptions to healthcare delivery during th...

Kolade Olatunde · 0 citations
Review Open access Oct 2026

Medicare Prescription Payment Plan (MPPP): Awareness, utilization, and barriers among people with cancer.

175 Background: MPPP allows people with Medicare prescription drug coverage (Part D) to spread drug costs over the year. Given high costs of many cancer prescription drugs, patients may benefit from smaller monthly payments rather than large upfront costs. Despite potential to reduce financial burden and access...

Alexandra K. Zaleta, K. Czubaruk, Julie S. Olson et al. · 0 citations
Open access Oct 2026

The geography of coverage: Payer mix differences across area deprivation index levels in community oncology.

265 Background: Insurance coverage is a key determinant of access to cancer care and may vary substantially across communities with differing socioeconomic conditions. The Area Deprivation Index (ADI) is a validated measure of neighborhood-level socioeconomic disadvantage that incorporates indicators of income,...

Altamash Rahman, Stephen G. Divers, B. Mulherin et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.